Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Pregnancy category: B Discontinuation of treatment in a pregnant woman with primary systemic carnitine deficiency may carry serious consequences
Retatrutide is expected to complete Phase 3 trials in 20252026, with a potential FDA submission in 20262027
Like GLP-1s, amylin analogs act on brain receptors but have distinct mechanisms of action and functions
Importantly, individuals with higher baseline external eating scores experienced greater body weight reduction, highlighting a potentially underexplored predictor of GLP-1RA efficacy
US$ 24.36
US$ 22.48
US$ 21.12
US$ 20.25
US$ 22.82
